Taipei, Taiwan

Yuh-Shan Jou

USPTO Granted Patents = 2 

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yuh-Shan Jou: Innovator in Cancer Treatment

Introduction

Yuh-Shan Jou is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Jou's work focuses on developing novel therapeutic approaches to combat cancer.

Latest Patents

One of Jou's latest patents is titled "Plasmid encoding a c-terminal fragment of paraspeckle component 1 for treating tumors." This invention discloses an isolated nucleic acid that encodes a C-terminal fragment of the paraspeckle component 1 (PSPC1). The fragment exhibits biological activity against tumor cells associated with PSPC1 or protein tyrosine kinase 6 (PTK6). The anti-tumor activity includes suppressing tumor cell growth, progression, and metastasis, as well as decreasing the expression of PSPC1 and oncogenic PTK6 in the cytoplasm. Additionally, a reagent kit and method for predicting tumor progression and prognosis in cancer patients are also part of this patent.

Another significant patent by Jou is "Dipyridamole for use in treating SLC29A2 nuclear-expressing cancer." This invention involves a pharmaceutical composition that includes an inhibitor of the oncogene SLC29A2. The composition aims to suppress the proliferation and metastasis of cancer cells overexpressing SLC29A2, ultimately prolonging patient survival. The inhibitor may include compounds such as dipyridamole and its derivatives, and the composition may also contain sorafenib for enhanced efficacy.

Career Highlights

Yuh-Shan Jou is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work has garnered attention for its potential impact on cancer therapies, showcasing his dedication to advancing medical science.

Collaborations

Jou has collaborated with notable colleagues, including Yaw-Dong Lang and Hsi-Wen Yeh, who contribute to his research endeavors. Their combined expertise enhances the quality and scope of their work in cancer treatment.

Conclusion

Yuh-Shan Jou's innovative patents and research in cancer treatment highlight his significant contributions to the field. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…